Copyright
©The Author(s) 2018.
World J Clin Cases. Apr 16, 2018; 6(4): 44-53
Published online Apr 16, 2018. doi: 10.12998/wjcc.v6.i4.44
Published online Apr 16, 2018. doi: 10.12998/wjcc.v6.i4.44
TBA > 8 | TBA < 8 | P value | |
(n = 80) | (n = 1190) | ||
TBA (mean ± SD, μmol/L) | 14.66 ± 1.24 | 3.07 ± 0.06 | 6.15 × 10-144 |
Alkaline phosphatase (mean ± SD, U/L) | 81 ± 5.81 | 69.3 ± 1.25 | 0.021 |
Albumin (mean ± SD, g/L) | 38.0 ± 0.92 | 39.9 ± 0.21 | 0.017 |
Vitamin D | 25 (31) | 254 (21) | 0.038 |
Vitamin E | 2 (3) | 9 (1) | 0.103 |
Calcium | 30 (38) | 336 (28) | 0.076 |
Prednisone | 16 (20) | 160 (13) | 0.100 |
Azathioprine | 37 (46) | 383 (32) | 0.009 |
Smokers | 12 (15) | 330 (28) | 0.012 |
Thrombosis | 4 (5) | 17 (1) | 0.015 |
- Citation: Girardin M, Hadengue A, Frossard JL, the Swiss IBD Cohort Study Group. High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients. World J Clin Cases 2018; 6(4): 44-53
- URL: https://www.wjgnet.com/2307-8960/full/v6/i4/44.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v6.i4.44